Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	ARGXargenx SE	REGNRegeneron Pharmaceuticals	ONCBeOne Medicines AG
Snapshot
Price	$1031.82	$832.10	$372.18
Market cap	$55.53B	$68.59B	$33.43B
Valuation
P/E	26x	19.8x	71.9x
Forward P/E	18.6x	19x	—
Growth
Revenue growth	80.6%	5.9%	36.2%
EPS growth	111.4%	4.4%	—
Profitability
Net margin	48.2%	29.6%	7.8%
ROE	22.9%	14.3%	5.2%
Balance sheet & cash
Debt / equity	0.01x	0.09x	0.25x
Free cash flow yield	—	6.3%	—
Dividend yield	—	0.6%	—
Verdict
Investment rating	Strong· 88	Favorable· 69	Neutral· 48

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	ARGXtoday $1032	REGNtoday $832	ONCtoday $372
2027	$1,636.11 – $2,399.62+133% CAGR	$651.53 – $955.58+15% CAGR	$380.13 – $557.52+50% CAGR
2028	$3,459.05 – $5,073.28+122% CAGR	$680.20 – $997.63+9% CAGR	$517.66 – $759.23+43% CAGR
2029	$7,313.13 – $10,725.93+118% CAGR	$710.13 – $1,041.53+8% CAGR	$704.94 – $1,033.92+41% CAGR
2030	$15,461.42 – $22,676.75+117% CAGR	$741.38 – $1,087.35+7% CAGR	$959.99 – $1,407.99+39% CAGR
2031	$32,688.54 – $47,943.19+115% CAGR	$774.00 – $1,135.20+6% CAGR	$1,307.32 – $1,917.40+39% CAGR
5-yr CAGR	99.6% – 115.5%	-1.4% – 6.4%	28.6% – 38.8%